Pennsylvania SB1215 amends the Workers' Compensation Act to set reimbursement rates for compound and noncompound topical drugs.
Pennsylvania SB1215 amends the Workers' Compensation Act to establish reimbursement rates for compound and noncompound topical drugs. For compound drugs, reimbursement is calculated per ingredient, with a maximum of $400 per thirty-day supply. Noncompound drugs are reimbursed at the lesser of 110% of the Average Wholesale Price, the Federal Upper Limit, or $240 per thirty-day supply. The bill also defines "compound drug" and "topical drug" and specifies that drugs essentially duplicating commercially available products are not reimbursable.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.